Million Dollar Donation for Cancer Research Center

Translate to Spanish or other 102 languages!

City of McAllen Mayor Javier Villalobos and the McAllen City Commissioners recently approved a one million dollar donation to the University of Texas-RGV for the development of a cancer research center in the region. Image for illustration purposes. Courtesy Images
City of McAllen Mayor Javier Villalobos and the McAllen City Commissioners recently approved a one million dollar donation to the University of Texas-RGV for the development of a cancer research center in the region. Image for illustration purposes. Courtesy Images: City of Mcallen, utsystem.edu

Mega Doctor News

- Advertisement -

McALLEN, Texas – City of McAllen Mayor Javier Villalobos and the McAllen City Commissioners recently approved a one million dollar donation to the University of Texas-RGV for the development of a cancer research center in the region.  The donation will be added to the funding recently approved by the UT System Board of Regents for this endeavor. 

“I would like to congratulate UTRGV President Dr. Bailey for his leadership in helping to make a cancer research center in the Rio Grande Valley a reality,” said Mayor Villalobos.  “This research institute will have a tremendous and positive impact on the health and well-being of the entire region, opening up our community to not only having medical students trained here in a medically underserved area, but also, allowing our residents the opportunity to be a part of cancer medical research, helping to treat many of the illnesses that plague this region.  The City of McAllen is proud to make this donation for development of this cancer research center.”

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

What Persistent Fatigue Might Be Telling You

Mega Doctor News CLEVELAND CLINIC - We’ve all had those days where we’re...

AMA Unveils New Initiative to Boost Nutrition Education Nationwide

The American Medical Association (AMA) is launching a nutrition education initiative to equip physicians and medical students with practical, evidence-based knowledge and tools to help patients live healthier lives.

DHR Health to Host Headache Symposium to Address Gap in Neurological Care, March 28th

In the United States, headaches remain a common health concern, affecting approximately one in six Americans. Migraines, a type of headache, are the second leading cause of years lived with disability nationwide.

Study Finds GLP‑1 Therapy Reduces Heart and Kidney Risks for Type 1 Diabetes Patients

People with type 1 diabetes who took GLP-1 receptor agonist (GLP-1-RA) drugs for weight loss or better blood-sugar control had significantly reduced risks of major cardiovascular events and end-stage kidney disease without any increase in safety concerns, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.
- Advertisement -